Investment Rating - The investment rating for the company is "Buy" and is maintained [8] Core Views - The company is projected to achieve operating revenue of 189.5 billion yuan in 2025, representing a year-on-year growth of 1.97%. The net profit attributable to shareholders is expected to be 6.436 billion yuan, an increase of 13.15% year-on-year, while the net profit after deducting non-recurring items is forecasted to be 6.090 billion yuan, up 10.44% year-on-year [5][11] Financial Performance - The engineering business is expected to generate total revenue of 178.133 billion yuan in 2025, with a year-on-year growth of 1.59%, accounting for 94% of total revenue, a slight decrease of 0.27 percentage points. The industrial business is anticipated to contribute significantly, with revenue of 9.754 billion yuan, a year-on-year increase of 11.47%, representing 5.13% of total revenue, an increase of 0.44 percentage points year-on-year [11] - The gross margin is projected to improve significantly, reaching 10.71% in 2025, an increase of 0.60 percentage points year-on-year. The gross margins for engineering and industrial segments are expected to rise by 0.58 and 1.16 percentage points, respectively [11] - The cash collection ratio is expected to improve to 105.34%, a significant increase of 13.63 percentage points year-on-year, although the net cash flow from operating activities is projected to be only 1.443 billion yuan, a decrease of 7.279 billion yuan year-on-year [11] - The company achieved all incentive targets, with a net profit of 6.090 billion yuan, meeting the target of a 15% growth from the 2021 performance base [11] Future Outlook - The company is expected to see net profits of 6.885 billion yuan, 7.623 billion yuan, and 8.401 billion yuan for the years 2026, 2027, and 2028, respectively, corresponding to price-to-earnings ratios of 8.10, 7.31, and 6.64 [11]

Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Viewpoints - The price of hexamethylenediamine (HMD) has been on the rise, with a significant increase in demand and pricing due to tight supply and rising raw material costs. The price dropped to a low of 17,100 RMB/ton by the end of 2025 but has since increased to 18,200 RMB/ton in early 2026, marking a cumulative increase of 1,100 RMB [2][11]. - The company is expected to benefit from the recovery in the chemical industry, with a focus on the price increases of chemical products leading to profit elasticity. The company has a diverse chemical portfolio, including products like adiponitrile and caprolactam, which are anticipated to contribute positively to earnings in 2026 [11]. - The company has signed new contracts worth 403.66 billion RMB in 2025, reflecting a year-on-year increase of 10%. This growth in orders is expected to support stable earnings growth, with a projected double-digit growth rate for the year [11]. - The asset quality of the company is significantly undervalued, with approximately 80% of new contracts coming from chemical engineering projects with reputable clients. The company has a strong cash position, with 38 billion RMB in cash and a net cash position of 21 billion RMB, indicating a low valuation at 0.9x PB [11]. Summary by Relevant Sections Price Trends - HMD prices peaked at 26,500 RMB/ton in April 2024, followed by a decline to 17,100 RMB/ton by the end of 2025. Starting January 2026, prices began to rise again, with three consecutive increases leading to a price of 18,200 RMB/ton [5][11]. Financial Performance - The company is projected to achieve total revenue of 254.6 billion RMB in 2026, with a gross profit margin of approximately 10% [14]. - The net profit for 2026 is expected to reach 7.8 billion RMB, with earnings per share (EPS) projected at 1.28 RMB [14]. Market Position - The company has a strong market position with a diverse portfolio in the chemical sector, including significant production capacities for various chemical products. The anticipated recovery in the chemical industry is expected to enhance profitability [11].